Antenatal Receipt of Sulfadoxine-Pyrimethamine Does Not Exacerbate Pregnancy-Associated Malaria Despite the Expansion of Drug-Resistant Plasmodium falciparum: Clinical Outcomes From the QuEERPAM Study

Background. Antenatal intermittent preventive therapy with 2 doses of sulfadoxine-pyrimethamine (IPTp-SP) is the mainstay of efforts in sub-Saharan Africa to prevent pregnancy-associated malaria (PAM). Recent studies report that drug resistance may cause IPTp-SP to exacerbate PAM morbidity, raising...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Taylor, Steve M., Antonia, Alejandro L., Chaluluka, Ebbie, Mwapasa, Victor, Feng, Gaoqian, Molyneux, Malcolm E., ter Kuile, Feiko O., Meshnick, Steven R., Rogerson, Stephen J.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2012
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3520448/
https://ncbi.nlm.nih.gov/pubmed/22441649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cis301
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados